0001171843-12-002425.txt : 20120628 0001171843-12-002425.hdr.sgml : 20120628 20120628213531 ACCESSION NUMBER: 0001171843-12-002425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120626 FILED AS OF DATE: 20120628 DATE AS OF CHANGE: 20120628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KASTEN BERNARD L CENTRAL INDEX KEY: 0001244745 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32954 FILM NUMBER: 12933880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CLEVELAND BIOLABS INC CENTRAL INDEX KEY: 0001318641 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200077155 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 73 HIGH STREET CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: (716) 849-6810 MAIL ADDRESS: STREET 1: 73 HIGH STREET CITY: BUFFALO STATE: NY ZIP: 14203 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0305 4 2012-06-26 0001318641 CLEVELAND BIOLABS INC CBLI 0001244745 KASTEN BERNARD L C/O CLEVELAND BIOLABS, INC. 73 HIGH STREET BUFFALO NY 14203 1 0 0 0 Common stock, par value $0.005 per share 2012-06-26 4 A 0 6342 0 A 26998 D These shares of restricted stock were granted to the reporting person under the Equity Incentive Plan, as amended, of Cleveland BioLabs, Inc. (the "Company"). The reporting person has elected to receive these shares of restricted stock in lieu of a portion of his cash compensation. These shares of restricted stock will become fully vested on December 16, 2012, unless the reporting person ceases to be an affiliate of the Company. /s/ Leah Brownlee, Attorney-in-fact for Bernard L. Kasten 2012-06-28